There is currently no effective treatment for Rett syndrome (RTT), a severe X-linked progressive neurodevelopmental disorder caused by mutations in the transcriptional regulator MECP2 (Amir et al., 1999). The gene discussed is MECP2; the disease is atypical Rett syndrome.